Tower Research Capital (TRC)’s Mesoblast MESO Stock Holding History
Bought
Maintained
Sold
Other funds holding MESO
PM
Tower Research Capital (TRC)'s MESO Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its Mesoblast (MESO) stake by 134% in Q1 2026, buying an estimated $23.1K and bringing the position to 2,419 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2996.
Tower Research Capital (TRC) first reported a position in MESO in Q4 2015 and has held it in 16 quarters since. The position peaked at $88.2K in Q4 2024. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.
- Tower Research Capital (TRC) held 2,419 shares of Mesoblast worth $37.2K as of Q1 2026.
- Tower Research Capital (TRC) bought 1,386 Mesoblast shares in Q1 2026, an estimated $23.1K.
- Mesoblast made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2996 holding.
- Tower Research Capital (TRC) first reported a position in Mesoblast in Q4 2015 and has held it in 16 quarters since.
- Tower Research Capital (TRC)'s Mesoblast position peaked at $88.2K in Q4 2024.
- 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.